Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Osteoporosis in HIV Patients
NCT00795483Phase 4Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Nov 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of zoledronic acid in osteoporosis (3 arms), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Bone Mineral Density T-score (Lumbar and Femoral) at 96 weeks. Started Nov 2009; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00795483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795483.